Decreased Expression of ZWINT is Associated With Poor Prognosis in Patients With HCC After Surgery

about

Decreased Expression of ZWINT is Associated With Poor Prognosis in Patients With HCC After Surgery

Item

http://www.wikidata.org/entity/Q58757343

description

scientific article published on 01 January 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в січні 2018

@uk

name

Decreased Expression of ZWINT ...... atients With HCC After Surgery

@en

Decreased Expression of ZWINT ...... atients With HCC After Surgery

@nl

type

Item

label

Decreased Expression of ZWINT ...... atients With HCC After Surgery

@en

Decreased Expression of ZWINT ...... atients With HCC After Surgery

@nl

prefLabel

Decreased Expression of ZWINT ...... atients With HCC After Surgery

@en

Decreased Expression of ZWINT ...... atients With HCC After Surgery

@nl

P1476

Decreased Expression of ZWINT ...... atients With HCC After Surgery

@en

P2093

Bin Wu

http://www.w3.org/2001/XMLSchema#string

Lei Yin

http://www.w3.org/2001/XMLSchema#string

Meng-Chao Wu

http://www.w3.org/2001/XMLSchema#string

Sen-Lin Ma

http://www.w3.org/2001/XMLSchema#string

Xiao-Yu Yang

http://www.w3.org/2001/XMLSchema#string

P2860

Human Zwint-1 specifies localization of Zeste White 10 to kinetochores and is essential for mitotic checkpoint signaling

CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery

Tissue microarrays for high-throughput molecular profiling of tumor specimens

Prognosis of hepatocellular carcinoma: the BCLC staging classification

HZwint-1, a novel human kinetochore component that interacts with HZW10.

Diagnostic value of PIVKA-II and alpha-fetoprotein in hepatitis B virus-associated hepatocellular carcinoma

ATAD2 as a Poor Prognostic Marker for Hepatocellular Carcinoma after Curative Resection

Re-evaluation of 6th edition of AJCC staging system for nasopharyngeal carcinoma and proposed improvement based on magnetic resonance imaging.

Clinical, pathological, proliferative and molecular responses associated with neoadjuvant aromatase inhibitor treatment in breast cancer.

Overexpression of androgen receptor enhances the binding of the receptor to the chromatin in prostate cancer.

P304

1533033818794190

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1533033818794190

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ai-Jun Li

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30198401

http://www.w3.org/2001/XMLSchema#string

P921

cancer research

P932

6131298

http://www.w3.org/2001/XMLSchema#string